These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 30365074)

  • 1. Long term exposure to γ‑rays induces radioresistance and enhances the migration ability of bladder cancer cells.
    Mao G; Yao Y; Kong Z
    Mol Med Rep; 2018 Dec; 18(6):5834-5840. PubMed ID: 30365074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of autophagy-associated protein increased acquired radio-resistance bladder cancer cells sensitivity to taxol.
    Ma X; Mao G; Chang R; Wang F; Zhang X; Kong Z
    Int J Radiat Biol; 2021; 97(4):507-516. PubMed ID: 33443463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 enhances radiation-induced tumor migration, invasion and stem-like properties of bladder cancer.
    Wang F; Ma X; Mao G; Zhang X; Kong Z
    Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cdc20 induces the radioresistance of bladder cancer cells by targeting FoxO1 degradation.
    Wang L; Yang C; Chu M; Wang ZW; Xue B
    Cancer Lett; 2021 Mar; 500():172-181. PubMed ID: 33290869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ATM inhibitor KU55933 sensitizes radioresistant bladder cancer cells with DAB2IP gene defect.
    Zhang T; Shen Y; Chen Y; Hsieh JT; Kong Z
    Int J Radiat Biol; 2015 Apr; 91(4):368-78. PubMed ID: 25585815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulating DAB2IP expression via EGR-1 inhibition, a new approach for overcoming fractionated-irradiation-induced cross-tolerance to ionizing radiation and mitomycin C in tumor cells.
    Chang R; He H; Mao G; Kong Z
    Int J Radiat Biol; 2017 Apr; 93(4):386-393. PubMed ID: 27834104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exposure to fractionated dose of 60 Gy affects molecular response of HL-60 cells to irradiation.
    Vávrová J; Tichý A; Rezáčová M; Zárybnická L; Sinkorová Z; Osterreicher J
    Gen Physiol Biophys; 2010 Sep; 29(3):275-81. PubMed ID: 20817951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA Inhibits Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Modulation of STAT3-CCL2 Signaling.
    Huang SY; Chang SF; Liao KF; Chiu SC
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28757590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
    Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
    Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Explaining differences in sensitivity to killing by ionizing radiation between human lymphoid cell lines.
    Aldridge DR; Radford IR
    Cancer Res; 1998 Jul; 58(13):2817-24. PubMed ID: 9661896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lovastatin sensitizes lung cancer cells to ionizing radiation: modulation of molecular pathways of radioresistance and tumor suppression.
    Sanli T; Liu C; Rashid A; Hopmans SN; Tsiani E; Schultz C; Farrell T; Singh G; Wright J; Tsakiridis T
    J Thorac Oncol; 2011 Mar; 6(3):439-50. PubMed ID: 21258249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ionizing radiation on the viability and proliferative behavior of the human glioblastoma T98G cell line.
    Murad H; Alghamian Y; Aljapawe A; Madania A
    BMC Res Notes; 2018 May; 11(1):330. PubMed ID: 29784026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ATM mediates DAB2IP-deficient bladder cancer cell resistance to ionizing radiation through the p38MAPK and NF-κB signaling pathway.
    He H; Chang R; Zhang T; Yang C; Kong Z
    Mol Med Rep; 2017 Aug; 16(2):1216-1222. PubMed ID: 28586028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation induces p53-dependent cell apoptosis in bladder cancer cells with wild-type- p53 but not in p53-mutated bladder cancer cells.
    Hinata N; Shirakawa T; Zhang Z; Matsumoto A; Fujisawa M; Okada H; Kamidono S; Gotoh A
    Urol Res; 2003 Dec; 31(6):387-96. PubMed ID: 12955365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased DAB2IP gene expression, which could be induced by fractionated irradiation, is associated with resistance to γ‑rays and α‑particles in prostate cancer cells.
    Yang C; He H; Zhang T; Chen Y; Kong Z
    Mol Med Rep; 2016 Jul; 14(1):567-73. PubMed ID: 27177018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytostatic in vitro effects of DTCM-glutarimide on bladder carcinoma cells.
    Brassesco MS; Pezuk JA; Morales AG; de Oliveira JC; Valera ET; da Silva GN; de Oliveira HF; Scrideli CA; Umezawa K; Tone LG
    Asian Pac J Cancer Prev; 2012; 13(5):1957-62. PubMed ID: 22901154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers.
    Kim JS; Kim HA; Seong MK; Seol H; Oh JS; Kim EK; Chang JW; Hwang SG; Noh WC
    Oncotarget; 2016 Feb; 7(6):7055-65. PubMed ID: 26755645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin enhances the response of non-Hodgkin's lymphoma cells to ionizing radiation through further induction of cell cycle arrest at the G2/M phase and inhibition of mTOR phosphorylation.
    Qiao Q; Jiang Y; Li G
    Oncol Rep; 2013 Jan; 29(1):380-6. PubMed ID: 23117293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the phosphorylation of ATM contributes to radioresistance of glioma stem cells.
    Zhou W; Sun M; Li GH; Wu YZ; Wang Y; Jin F; Zhang YY; Yang L; Wang DL
    Oncol Rep; 2013 Oct; 30(4):1793-801. PubMed ID: 23846672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.